Aster DM Healthcare was represented by Rahul Kadavakolu, Group Chief Marketing Officer, while Boehringer Ingelheim was represented by Ousama Alhaj, General Manager and Head of Human Pharma for the Near East and UAE, alongside Ghaleb Al Ahdab, Head of Public and Government Affairs for the Near East and UAE.
The newly formed organization brings together four established healthcare brands including Aster DM, CARE Hospitals, Evercare and KIMSHEALTH, under a single platform focused on expanding access to advanced and affordable medical care across the country.
The centre will treat patients with a broad range of conditions, including stroke, spinal cord injuries, traumatic brain injuries, multiple sclerosis, cerebral palsy, autism spectrum disorder, muscular dystrophy, motor neuron disease, movement disorders, Alzheimer’s disease, dementia, ataxia, and dystonia.
The initiative combines “Care for Her” by Aster Hospitals & Clinics and “Elle by Medcare,” a premium programme offered through Medcare hospitals and medical centres.
Under Aster’s management, the hospital will adopt the group’s integrated healthcare model, global quality standards, and patient-centred approach to care.
The shortlisted finalists represent a diverse mix of healthcare professionals who have demonstrated leadership, innovation, and commitment to patient care in different parts of the world.
A defining feature of the ranking methodology is its reliance on globally recognized tools such as Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs).
The partnership operates under Aster Volunteers, reinforcing Aster’s commitment to organised and impact-driven outreach.
The organization recorded an overall Trust Index score of 82%, alongside an employee participation rate of 88%.
The merger is set to complete within the next quarter, pending final regulatory and statutory approvals from the National Company Law Tribunal (NCLT).